About CBD


Cannabidiol is a nonpsychoactive substance extracted from hemp plants

Hemp is the common name for plants of the entire genus Cannabis, but the term is often used to refer only to Cannabis strains cultivated for industrial (non-drug) use. There are two strains of Cannabis: Indica and Sativa, each with different components and effects. Both strains contain THC and CBD with the plants containing less than 0.3% THC considered to be industrial hemp. Industrial hemp usually has higher levels of CBD (up to 5% in some variations).

The use of hemp is not new. There is evidence that industrial hemp has been used as medicine for over 10,000 years and its use as food, textile, and paper was wide spread. In fact, the original flag of the United States was made of hemp fibre. More recently, the construction, automotive, pharmaceutical and cosmeutical industries have started utilizing this amazing plant. Research and testing of CBD is showing tremendous benefits in health and well-being and doctors and researchers around the world are exploring its possible uses with demonstration of its efficacy as: anti-convulsion,  anti-psychotic, anti-inflammatory, anti-depressive, antioxidant, and anti-tumoral.

Different varieties of hemp have different qualities. The Serbian hemp cultivated by Eviana is clean, and organic with the highest levels of CBD (5%) making it highly sought after.

Some Positive Effects of CBD

  • Among patients with the Dravet syndrome, CBD resulted in a greater reduction in convulsive-seizure frequency than placebo. See the original article about this topic here
  • CBD may be an effective and well-tolerated treatment option for patients with refractory seizures in TSC (Tuberous Sclerosis Complex). See the original article about this topic here
  • CBD Turns Off Gene Known to Spread Cancer
  • The first patient to receive CBD oil for brain cancer in Orlando says it is a huge help to her as she hopes to extend her life. See more here

About Cannabidiol (CBD)

Cannabidiol (CBD) is one of the naturally occurring cannabinoids found in cannabis plants. It is a 21-carbon terpenophenolic compound which is formed following decarboxylation from a cannabidiolic acid precursor, although it can also be produced synthetically.

The genus Cannabis belong to the family Cannabaceae. Generally, cannabis is considered to be monospecific (Cannabis sativa L.) which is divided into three subspecies: C. sativa subsp. sativa, C. sativa subsp. indica, and C. sativa subsp. ruderalis. Industrial hemp (C. sativa subsp. sativa) comprises a number of varieties of Cannabis sativa L. that are intended for agricultural and industrial purposes; it is characterized by high CBD content and low tetrahydrocannabinol (THC) content. In most European countries the current upper legal limit for cultivation is 0.2 % THC (Canada: 0.3 %). The ratio of CBD to THC is about 20:1-25:1.

Cannabis has been used as an agricultural crop for textile fibres for centuries. Other legitimate cannabis products include cannabis seed, cannabis seed oil and the essential oil of cannabis. Hemp extracts are important part of the rapidly growing cannabis industry, especially in medical markets. The essential oil of cannabis, which is a concentrate of all the active pharmaceutical ingredients in the hemp plant (cannabinoids, terpenes, amino acids, fatty acids, hydrocarbons, flavonoids, sugars, etc.), is a dynamic substance that can be transformed into numerous forms for user consumption. Hemp’s therapeutic potential is attributable to the valuable overlap between phytocannabinoids (i.e. plant-derived cannabinoids) and the endogenous cannabinoid system in humans, termed a “therapeutic handshake.” While THC activity in the body is fairly well elucidated (it acts through G-protein coupled cannabinoid receptor 1 and cannabinoid receptor 2), CBD’s pharmacokinetics are less well understood (no specific receptor for CBD has been identified). The scientific understanding of CBD’s clinical effects is based mostly on studies in specific indications, like epilepsy. Epidiolex (highly potent, pure formulation of CBD) was approved in 2018 for the treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome. Additional possible indications for CBD products include autism spectrum disorders, psychiatric conditions, diabetic neuropathy pain, fibromyalgia, chronic pain, and back pain; clinical trials in these indications are underway.

Copyright © Eviana Health Corporation, Inc.